ArticleCancer discovery2013

Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation.

Anna Sukhanova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.